Cargando…

HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice

People who inject drugs (PWID) and prisoners are considered key populations at risk for human immunodeficiency virus (HIV) and/or Hepatitis C Virus (HCV). In 2016, the Joint United Nations Program on HIV/AIDS (UNAIDS) was implemented to eliminate HIV and AIDS by 2030 and the World Health Organizatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stöver, H., Dichtl, A., Schäffer, D., Grabski, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10100628/ https://www.ncbi.nlm.nih.gov/pubmed/37055763 http://dx.doi.org/10.1186/s12954-023-00774-1

Ejemplares similares

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Prisoners should not be left behind in HCV research and policies
por: Moazen, Babak, et al.
Publicado: (2020)

Prison‐based interventions are key to achieving HCV elimination among people who inject drugs in New South Wales, Australia: A modelling study
por: Stone, Jack, et al.
Publicado: (2022)

Modelling the impact of incarceration and prison‐based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in Scotland
por: Stone, Jack, et al.
Publicado: (2017)

Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel
por: Fiore, Vito, et al.
Publicado: (2022)

Sofosbuvir plus Ribavirin is effective for HCV elimination in people living with HIV from rural area of China
por: Chen, Liyu, et al.
Publicado: (2021)

Collaboration with people with lived experience of prison: reflections on researching cancer care in custodial settings
por: Visser, Renske, et al.
Publicado: (2021)

Opioid substitution therapy for people living in German prisons—inequality compared with civic sector
por: Stöver, Heino, et al.
Publicado: (2019)

A retrospective study to find the prevalence of HIV, HCV and dual HIV-HCV infection in the prison inmates
por: Singh, Gur Parkash, et al.
Publicado: (2022)

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies
por: Krauth, Christian, et al.
Publicado: (2019)

Pilot Outreach Program in Remedis—The Promising Step toward HCV Elimination among People Who Inject Drugs
por: Krekulová, Laura, et al.
Publicado: (2022)

HCV seroconversion in a cohort of people who use drugs followed in a mobile harm reduction unit in Madrid: Breaking barriers for HCV elimination
por: Valencia La Rosa, Jorge, et al.
Publicado: (2018)

COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review
por: Ismail, Nasrul, et al.
Publicado: (2022)

The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases
por: Stöver, Heino, et al.
Publicado: (2021)

Suicide in Older Prisoners in Germany
por: Opitz-Welke, Annette, et al.
Publicado: (2019)

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
por: Leyna, Germana Henry, et al.
Publicado: (2019)

Elimination of HCV as a public health concern among people who inject drugs by 2030 – What will it take to get there?
por: Grebely, Jason, et al.
Publicado: (2017)

It may take many villages, but progress can be made toward HCV elimination among people who inject drugs
por: Page, Kimberly
Publicado: (2023)

Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisons
por: Martin, Natasha K, et al.
Publicado: (2013)

Remaining challenges in HCV elimination
por: Capraru, Camelia, et al.
Publicado: (2021)

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe
por: Stöver, H., et al.
Publicado: (2019)

Establishing a framework towards monitoring HCV microelimination among men who have sex with men living with HIV in Germany: A modeling analysis
por: Marquez, Lara K., et al.
Publicado: (2022)

Comparison of the Efficacies of Direct-Acting Antiviral Treatment for HCV Infection in People Who Inject Drugs and Non-Drug Users
por: Hsu, Jui-Ting, et al.
Publicado: (2022)

Prisons: an important link in the elimination of Hepatitis B
por: Barreira-Díaz, A, et al.
Publicado: (2021)

HCV and HIV co-infection among people who inject drugs in Vietnam
por: THINH, Vu Toan, et al.
Publicado: (2020)

Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil
por: Puga, Marco Antonio Moreira, et al.
Publicado: (2017)

Telemedicine and specialised consultations in prisons. The example of HCV chronic hepatitis
por: Fernández Rodríguez, C, et al.
Publicado: (2019)

Elimination of HCV in Russia: Barriers and Perspective
por: Isakov, Vasily, et al.
Publicado: (2022)

HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects
por: Fiore, Vito, et al.
Publicado: (2022)

The discourses of risk of drug users in prison
por: Clua-García, R, et al.
Publicado: (2019)

Reduced Independence in Daily Living Is Associated with the Gut Microbiome in People with HIV and HCV
por: Taylor, Bryn C., et al.
Publicado: (2020)

Incidence and Risk Factors of Reinfection with HCV after Treatment in People Living with HIV
por: Cheng, Chien-Yu, et al.
Publicado: (2022)

Reflecting on 2022
por: Clarke, Joanna
Publicado: (2022)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Patient and public involvement (PPI) in prisons: the involvement of people living in prison in the research process – a systematic scoping review
por: Treacy, Samantha, et al.
Publicado: (2021)

Distribution of HCV Genotypes Among People Who Inject Drugs in Tunisia: New Evidence for Scaling Up Prevention and Treatment Toward National Elimination Goal
por: Chouikha, Anissa, et al.
Publicado: (2021)

Can Telemedicine Optimize the HCV Care Cascade in People Who Use Drugs? Features of an Innovative Decentralization Model and Comparison with Other Micro-Elimination Strategies
por: Nevola, Riccardo, et al.
Publicado: (2022)

Epidemiology and Elimination of HCV-Related Liver Disease
por: Pradat, Pierre, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_u5jpkkjoo6ebapnjuj1a19tole